Indication

Botulism

9 clinical trials

10 products

1 drug

Product

Blood sample collection

Clinical trial

Pharmacokinetics of Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) - (Equine) (BAT®) in Pediatric Patients With a Confirmed or Suspected Exposure to Botulinum Neurotoxin

Status: , Estimated PCD: 2027-07-31

Product

Clinical trial

Botulinum Antitoxin Patient Registry for the Evaluation of Safety and Clinical Outcomes of Pediatric and Adult Patients Following BAT Treatment for Confirmed or Suspected Exposure to Botulinum Toxin.

Status: Completed, Estimated PCD: 2017-07-01

Clinical trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacodynamics, and Immunogenicity of a Repeat Dose of G03-52-01 in Adult Subjects

Status: Active (not recruiting), Estimated PCD: 2024-12-03

Product

Product

Clinical trial

Clinical Observation of Intradermal Injections With Botulinum Toxin A in the Treatment of Rosacea Erythema Telangiectasia

Status: Recruiting, Estimated PCD: 2024-03-01

Product

Botulinum Toxin Type A

Clinical trial

The Effect of Ultrasound-Guided Botulinum Toxin Injections on Pain, Functionality, Spasticity, and Range of Motion in Patients With Post-Stroke Upper Extremity Spasticity

Status: Withdrawn, Estimated PCD: 2023-07-15

Product

Botulinum toxin type A

Product

Clinical trial

Tolerability and Immunogenicity of a Single 40-µg Dose of Recombinant Botulinum Vaccine A/B (rBV A/B) for the Production of BabyBIG® in Volunteers With Existing Botulinum Immunity

Status: Not yet recruiting, Estimated PCD: 2025-09-01

Product

Clinical trial

Randomized Pilot Study Evaluating Effectiveness of Botulinum Toxin Type A in Freezing Walking in Parkinson's Disease

Status: Not yet recruiting, Estimated PCD: 2024-06-30

Clinical trial

The Effect of Botulinum Toxin A in Patients With Myofascial Pain Dysfunction Syndrome With and Without Zinc Supplementation (Randomized Controlled Trial)

Status: , Estimated PCD: 2023-04-20

Product

Drug

Clinical trial

A Proof of Concept Study of the Effect of Amifampridine (Firdapse®) on Neuromuscular Transmission in Patients Treated With OnabotulinumtoxinA (Botox®, BTX-A)

Status: Recruiting, Estimated PCD: 2024-06-01

Product